drugset / Trial / NCT06544798
Long-term Follow-up of Gene Therapy for Radiation-Induced Xerostomia
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will assess the long-term safety and efficacy of bilateral intra-parotid administration of AAV2-hAQP1 in adults with Grade 2 or Grade 3 radiation-induced late xerostomia.
Timeline
- Start
- 2024-08-02
- Primary completion
- 2032-02
- Completion
- 2032-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AAV2hAQP1 | Gene therapy (AAV / viral vector) | — | Other |
Indications
No indication recorded.